All News

Researchers to benefit by receiving a rapid and cost-effective scaled supply of new compounds.

Acquired business will enhance Recipharm’s scale and provide access to new customers and higher margin specialised technologies.

Company to increase the number of generic APIs in the company's development pipeline.

Agreement will enable customers to achieve easier scalability of processes ranging from lab-scale to commercial-scale production of biopharmaceuticals.

The India Expo Mart brings the event closer to Indian regulatory and legislative hub and will encourage international audiences.

The Wear Indicator Layer is expected to have a "huge impact" on customers' production.

Company has developed a standard feature for its customers to execute the EMVO conformance testing successfully.

TAOS matrix system and products hailed as potential ‘game changers’ in the field of regenerative medicine.

Much needed more efficient manufacturing processes for ADCs aren't being completed by pharma.

Money to be spent on augmenting capability and capacity for process development and scale up, handling of potent substances, crystallization studies and solid phase characterization.

‘Brexit taskforce’ will see Recipharm prioritise its preparations and invest in the necessary capabilities and equipment to ensure seamless operations post March 2019.

Forgotten markets of Africa and Arabia to see increased growth fuelled by international and domestic partnerships and imported APIs.

Company to streamline operations and capture cost synergies.

Testa Anayltical to discuss their latest developments and application advances in Light Scattering technology, GPC/SEC instrumentation and Zeta potential measurement.

New equipment allows Genvion to take customers from development through to commercial manufacture.

Tjoapack to perform the secondary packaging and assembly of product kits for supply to 25 European countries, the US, Canada and Australia.

New poster describes how the EAF4 module enabled simultaneous measurement of size and surface charge characteristics of antibodies and proteins.

Bosch's new Xelum R&D for continuous production of oral solid dosage forms ensures a short time-to-market and optimum dosing of APIs.

2018 event prepares for surge in international attendees as MAH nears national rollout.

Milan, Italy – Dipharma Francis S.r.l., (Dipharma), a leading European manufacturer of Active Pharmaceutical Ingredients, is pleased to communicate that it has completed its previously announced acquisition of Kalexsyn, Inc. (Kalexsyn), a world-...

Postponement printing is presenting interesting benefits for the pharmaceutical supply chain.

Site's reactor capacity is increased by 30%.

With the capacity expansion, Thermo Fisher will have the second largest base of single-use bioproduction capacity at a CDMO in the world.

Acquisition of AurKa Pharma expands Lilly's oncology pipeline with early-phase asset being studied in multiple tumour types.

Recipharm's Staffan Widengren, Director Corporate Projects, discusses why CMOs should be focusing on the value-added opportunities presented by serialisation.

In order to ensure a new manufacturing contract with Merck SA, Grupo Azevedos, an international pharmaceutical group, has invested 2M euros approx. in their own plant unit  Sofarimex with a new Groninger high-speed liquid filling line.
qq...

Allows for easy and intuitive scale-up from research.

Moehs group built a New Research Center,  A new state-of-the-art 2.762sqm facility. Full capacity and expert team for your projects.

Customers to gain a greater insight into their projects, better track project progress and improve communications.

Managing the risks associated with Industrial Hygiene and Quality and meeting operational efficiency targets.

New Industry 4.0 solutions from Bosch for more transparency.

Acquisition enables Ardena to manufacture batch sizes up to 100 kg.

Anmeal and Impax create diversified pharmaceutical company.

The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval.

NIAID-funded research could aid antimalarial drug development.

Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations for pharmaceutical manufacturers.

Integrated one-site solution for partners to push forward innovative APIs and advanced intermediates from preclinical to commercial stage.

Global Drug Supply, Safety and Traceability Report reveals disparity in industry’s readiness to comply with track and trace regulations in the US and EU.

Energy efficient, short cycle times and reliable product quality in large batches.

Retrofitting made easy

New Display and Operating Concept for the ALPINE Air Jet Sieve e200 LS

The latest air jet sieve in the family of ALPINE's air jet sieves e200 LS is the device for analysing the part...

Company to bring its new services and products into the spotlight at ACHEMA.

The aboratory’s primary function is to broaden analytical support for customer projects being developed and manufactured at the High Point site.

The CDMO's US sales have increased from £15.5 million to £41 million since 2016.

Sartorius Stedim Biotech introduces its mini microcarrier bioreactor for culturing adherent cells.

Dipharma Francis S.r.l. (Dipharma), a leading European manufacturer of Active Pharmaceutical Ingredients, and Kalexsyn, Inc. (Kalexsyn), a world-class Contract Research Organization (CRO) providing chemistry services to the biotechnology and pharmaceut...

Investment enhances the CDMO's scale-up and small to midscale commercial API manufacturing capabilities.

Grabs, Switzerland: – Top-loading parenteral and secondary packaging specialist Dividella has set a new benchmark for high speed parenteral packaging with its latest NeoTRAY fully automatic family of cartoners that supports outputs up to 40 million...

The contract manufacturer strengthens its pharmaceutical-protein business with Dutch acquisition

First customers have implemented portfolio changes.

MD-026 is the first RSK inhibitor to demonstrate potential disease-modifying properties in triple-negative breast cancer.

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products. Cobra Biologics ("Cobra")  today announced that it has been awarded the Queen’s ...

Sale of oncology business unlocks embedded value within Shire’s portfolio and sharpens focus on core areas reinforcing the company's leadership in rare diseases.

A new method of lyophilisation or freeze drying that uses a single, sterilisable, closed vessel to deliver lump free, fine powder product has the capability to revolutionise the production of bulk pharmaceutical powders. With the benefits of improve...

Posted February 22, 2018 in Announcements

Princeton, NJ – (February 22, 2018) Systech International, a global technology leader in brand protection, authentication, and product safety today announced enhanced functiona...

Posted January 12, 2018 in Announcements

Brussels, Belgium – (January 12, 2018) Systech International, the global technology leader in serialisation, track and trace, and brand protection grew its European presence in ...

Posted November 22, 2017 in Announcements

Princeton, NJ – (November 22, 2017) Systech International, a global technology leader in serialization, product safety, and consumer and brand protection, and NKP Pharma, ...

Posted October 9, 2017 in Announcements

Princeton, NJ – (October 9, 2017) Systech International, a global technology leader in product safety, and consumer and brand protection, and Toppan, a leading integrated pr...

Investment will focus on the rapid and successful development of processes to supply clinical and commercial demand for chemical syntheses.

Carbon footprint reduced by more than 70%.

Expansion meets the demand for additional capacity to serve large-scale clinical studies and provides the space for future growth.

NIH-funded study finds omega-3 fails to yield beneficial results in the clinic.

New Toronto facility is one of the largest-ever investments by Sanofi in a single building.

Purpose-built compliance solution for smaller pharmaceutical companies.

First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.

SVP250 LF processing system minimizes product loss thanks to conical vessel shape.

Revolutionary, innovative plant offers greater flexibility, speed and efficiency.

The event will annually switch between Indonesia and Thailand to cater to attendees that were previously unable to participate.

Company set to triple its aseptic production capacity of injectable and lyophilized products.

The IHD series has been specially designed for coating and granulating pharmaceutical products with hot greases and waxes.

Pharma Liquid World shows the connection of a preparation system and filling machine, as well as robotic technology in aseptic filling.

With the new, intuitively operable control and evaluation software PAQXOS, Sympatec supports first time users as well as experts during particle characterisation. A newly developed, freely adaptable user interface, fully automated system detection, int...

The company’s environmental efforts honored for the fourth consecutive year.

With the acquisition of Irvine Scientific, FujiFilm will have a full product line supporting customers supplying antibody drugs to assisted reproductive technologies and cell therapy.

Servier CDMO is proud to announce we have been recognized across 11 categories in the 2018 CMO Leadership Awards, meeting or exceeding customer expectations in the core categories of Capabilities, Compatibility, Expertise, Quality, Reliability and Serv...

BioDuro announces creation of AISF ([4-(Acetylamino)phenyl]-ImidodiSulfuryl diFluoride), a convenient, shelf-stable, crystalline reagent for the synthesis of fluorosulfates and sulfamoyl fluorides, in a research collaboration with Pfizer.

The investment makes Idifarma one of only three companies in the world offering this type of contract development and manufacturing spray drying service.

Customers stand to benefit from broader services covering their API, drug product, regulatory CMC and bioanalysis requirements.

Expansion increases the facility’s manufacturing capacity by 200 million unidoses/year.

Customers to benefit from off-site training and solution testing without the downtime in the manufacturing and packaging processes.

Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness.

Craigavon, N.I., 26 March 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, has been named as one of Ireland’s Best Managed companies in the Deloitte Best Managed Companies Awards programme.

FPS, leader company in the pharmaceutical and fine chemical fields, developing, manufacturing and installing worldwide its own range of Fine Size Reduction machines and Containment Solutions (Sterile and Highly Potent API), has recently d...

Extensive range of ready-to-use culture media available in bottles and plates.

Additional capacity expansion across several of the company's sites also strengthens the company's global market leadership in spray drying.

Bio and generic demand reflective of wider trends in the market – with overseas investments now prospering.

Unique, single-use perfusion system offers a fast-track to intensified cell culture process development.

Four out of 10 of the top selling facial scrub brands use clay, sugar, salt or fruits as alternatives to microbeads.

Manufacturing high potency drugs - the challenges and innovations to mitigate the risks.

Noramco selects AFC for its infrastructure and analytical capabilities to help meet growing demand.

Partnership enables production volumes of NLAB Saga chromatography material to increase from tens of kilograms to tens of tonnes.

B&W Tek, a leader in mobile spectroscopy innovations and solutions, is proud to announce that its STRaman™ portable Raman analyzer for See-Through (ST) analysis through opaque barriers is the recipient of the Pittcon Today Excellence Gold Award 2018.

We are currently looking for a regional pharmaceutical companies/distributors who can support us in (1) registration and (2)sales and marketing of our biopharmaceutical “Laennec inj”, targeting chronic hepatitis, cirrhosis, ALD and NAFLD. Other commerc...

Customers cite network connectivity, efficiency of partner onboarding, and seamless data exchange as significant differentiators.

First patient treated in Follicum’s Phase IIa study of FOL-005 for stimulation of hair growth.

PF-04958242 is an AMPA receptor potentiator designed to facilitate neurotransmission.

MedPharm invests in $0.75 million cutting-edge instrumentation to further automated testing and expands workforce.

Experts forecast the personalised medicines, intelligent packaging and regulatory deadlines as the industry's biggest development.

The agreement includes the manufacture of 600 million enteric, chewable and film-coated tablets.

Licensing agreement enables Recipharm to co-develop new value-added medicines for its customers utilising Altus’ patented Intellitab and Flexitab drug delivery technologies.

ASEAN Economic Community and relaxed rules on foreign ownership driving increases in international investment and partnerships.

biosyn chooses a solution that ensures on-time compliance and delivers the required scalability.

Handling of small tablet batches in OEB rated environments has never been easier. 
With our integrated Wash-In-Place-system the Futorque is the most compact tablet press on the market for production of hormon or toxic products in the pharmaceut...

Expansions to meet safety requirements for GMO S2 and BSL-2 biological products.

Craigavon, N.I., 28 February 2018 – Almac Group, the global contract pharmaceutical development and manufacturing organisation, today announced the completion of a £20 million investment in its cold chain management capabilities with the opening of a ...

Customers to have the option of one partner from concept to market for their encapsulated drug products

Proposed acquisition of Viralytics will add investigational oncolytic immunotherapy, Cavatak, to Merck's pipeline.

The SupaPore VPBA filter enabled 30% faster processing times than the company's current regime.

Gaining GLP/GMP accreditation to provide greater assurance of data integrity for clients looking to take their compounds to IND.

Agreement follows the recent opening of WuXi STA's oligonucleotide R&D labs in China and the US.

BASF's Hepaxa is the first product in the US specifically designed to address a buildup of fat in the liver in NAFLD patients.

Majority of patients with scalp psoriasis on Cosentyx (secukinumab) achieved clear skin at Weeks 12 and 24 and improved quality of life.

The Centers of Excellence will allow custoners to access customer-centric solutions.

New ! A medical device for the treatment of fungal nail infection (Onychomycosis). It is a unique formula which contains an “instant killer”, a mix of
ingredients penetrates into the nail fungus and kills the fungi on the nail surface withi...

Cobra Biologics, an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services, a contract manufacturing organisation (CMO) specialising in sterile Fill Finish, today...

Vetter innovations in aseptic production increases the competitiveness of its customers.

The scientific, chemical and pharmaceutical expertise will cover end-to-end development services, ranging from development of the active compound to providing dossiers for marketing authorisation applications in all major geographies.

Expansion will accommodate new scientists to service the increase in demand for the company's formulation development, performance testing and manufacturing services.

Screening for new marine-derived functional ingredients and bringing new patented products to the market.

Packaging innovation shows a clear focus on patient compliance and ease-of-use.

New manufacturing paradigm will save 25% of total costs and the need for proteinaceous A & G resins.